These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
    Author: Wolk A, Andersson SO, Mantzoros CS, Trichopoulos D, Adami HO.
    Journal: Lancet; 2000 Dec 02; 356(9245):1902-3. PubMed ID: 11130391.
    Abstract:
    Further well designed studies are urgently needed to clarify if use of prostate-specific antigen (PSA) as a diagnostic test for prostate cancer can be improved by incorporating measurements of serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding-protein 3 (IGFBP-3), and if these measurements might also identify men at higher risk.
    [Abstract] [Full Text] [Related] [New Search]